Advertisement

Deployment of New Carbon Nanostructure: Graphene for Drug Delivery and Biomedical Applications

  • Mahe TalatEmail author
  • O. N. Srivastava
Chapter
Part of the Advanced Structured Materials book series (STRUCTMAT, volume 79)

Abstract

Graphene, the well awarded and popularly known as 2D carbon allotrope, is a versatile material. Its unique physico-chemical properties finds its application in a wide range of areas ranging from quantum physics, nanoelectronics, energy research, catalysis and engineering of nanocomposites, biomaterials and drug delivery.In principle, it is possible to produce graphene from high purity graphite sheet. Since graphite is stacked layers of many graphene sheets, bonded together by week van der Waals force and if these forces are disrupted individual graphene sheets can be separated out. In the present chapter we will discuss different methods of the synthesis of graphene like LPCVD, CVD (Chemical Vapor Deposition), thermal exfoliation, arc discharge, electrochemical exfoliation and chemical reduction. Since graphene having an innate property of hydrophobicity have the tendency to agglomeration and insolubility. To overcome the aforementioned insolubility some functionality needs to be attached to the graphene sheet. Therefore, different methods of functionalization like covalent and non-covalent approaches are also discussed. The last part of the chapter will deal with the application of graphene particularly in the drug delivery and biomedical field.

Keywords

Graphene Exfoliation Functionalization Application Drug delivery 

Notes

Acknowledgments

Authors are grateful to Nano Science and Technology Initiative, Department of Science and Technology (DST), India for financial support. Authors also thank Prof. C.N.R. Rao, Prof. Shyam Sunder, Prof. A.M. Kayastha and all the lab members who are engaged and contributed directly and indirectly in the nanoscience research. Authors gratefully acknowledge the financial support from CSIR, and MNRE, New Delhi. One of the co-author M.T thanks WOS-A fellowship for the support.

References

  1. 1.
    A.K. Geim, K.S. Novoselov, The rise of graphene. Nat. Mater. 6, 183–191 (2007)CrossRefGoogle Scholar
  2. 2.
    K.S. Novoselov, A.K. Geim, S.V. Morozov, D. Jiang, Y. Zhang, S.V. Dubonos et al., Electric field effect in atomically thin carbon films. Science 306, 666–669 (2004)CrossRefGoogle Scholar
  3. 3.
    K.S. Kim, Y. Zhao, H. Jang, S.Y. Lee, J.M. Kim, K.S. Kim et al., Large-scale pattern growth of graphene films for stretchable transparent electrodes. Nature 457, 706–710 (2009)CrossRefGoogle Scholar
  4. 4.
    C. Berger, Z. Song, X. Li, X. Wu, N. Brown, C. Naud et al., Electronic confinement and coherencein patterned epitaxial graphene. Science 312, 1191–1196 (2006)CrossRefGoogle Scholar
  5. 5.
    S. Stankovich, D.A. Dikin, R.D. Piner, K.A. Kohlhaas, A. Kleinhammes, Y. Jia et al., Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 45, 1558–1565 (2007)CrossRefGoogle Scholar
  6. 6.
    L. Feng, L. Wu, X. Qu, New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv. Mater. 25, 168–186 (2013)CrossRefGoogle Scholar
  7. 7.
    G. Gonçalves, M. Vila, M.T. Portolés, M. Vallet-Regi, J. Gracio, P.A.A. Marques, Nano-graphene oxide: a potential multifunctional platform for cancer therapy. Adv. Healthcare Mater. (2013). doi: 10.1002/adhm.201300023 Google Scholar
  8. 8.
    K. Yang, L. Feng, X. Shi, Z. Liu, Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 42, 530–547 (2013)CrossRefGoogle Scholar
  9. 9.
    H. Shen, L. Zhang, M. Liu, Z. Zhang, Biomedical applications of graphene. Theranostics 2, 283–294 (2012)CrossRefGoogle Scholar
  10. 10.
    Z. Liu, J.T. Robinson, X.M. Sun, H.J. Dai, PEGylated nanographene oxide for delivery of water-insoluble cancer. drugs. J. Am. Chem. Soc. 130, 10876–10877 (2008)CrossRefGoogle Scholar
  11. 11.
    X.M. Sun, Z. Liu, K. Welsher et al., Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1, 203–212 (2008)CrossRefGoogle Scholar
  12. 12.
    V. Georgakilas, M. Otyepka, A.B. Bourlinos, V. Chandra, N. Kim, K.C. Kemp, P. Hobza, R. Zboril, K.S. Kim, Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications. Chem. Rev. 112(11), 6156–6214 (2012). doi: 10.1021/cr3000412 CrossRefGoogle Scholar
  13. 13.
    B. Long, M. Manning, M. Burke, B.N. Szafranek, G. Visimberga, D. Thompson, J.C. Greer, I.M. Povey, J. MacHale, G. Lejosne, D. Neumaier, J.Q. Aidan, Non-covalent functionalization of graphene using self-assembly of alkane-amines. Adv. Funct. Mater. 22, 717–725 (2012)CrossRefGoogle Scholar
  14. 14.
    Z. Liu, J.T. Robinson, X.M. Sun, H.J. Dai, PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876–10877 (2008)CrossRefGoogle Scholar
  15. 15.
    X.M. Sun, Z. Liu, K. Welsher et al., Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1, 203–212 (2008)CrossRefGoogle Scholar
  16. 16.
    C.P. Thakur, A.K. Pandey, G.P. Sinha, S. Roy, K. Behbehani, P. Olliaro, Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans. R. Soc. Trop. Med. Hyg. 90(3), 319–322 (1996)CrossRefGoogle Scholar
  17. 17.
    S. Sundar, M. Chatterjee, Visceral leishmaniasis—current therapeutic modalities. Indian J. Med. Res. 123(3), 345–352 (2006)Google Scholar
  18. 18.
    V.K. Prajapati, K. Awasthi, S. Gautam et al., Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functional-ized carbon nanotubes. J. Antimicrob. Chemother. 66(4), 874–879 (2011)CrossRefGoogle Scholar
  19. 19.
    V.K. Prajapati, K. Awasthi, T.P. Yadav, M. Rai, O.N. Srivastava, S. Sundar, An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis. J. Infect. Dis. 205(2), 333–336 (2012)CrossRefGoogle Scholar
  20. 20.
    S.L. Mudavath, M. Talat, M. Rai, O.N. Srivastava, S. Sundar, Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies. Drug Des. Dev. Ther. 8, 1235–1247 (2014)Google Scholar
  21. 21.
    D. Kishore, M. Talat, O.N. Srivastava, A.M. Kayastha, Immobilization of b-Galactosidase onto functionalized graphene nano-sheets using response surface methodology and its analytical applications. PLoS ONE 7(7), e40708 (2012). doi: 10.1371/journal.pone.0040708 CrossRefGoogle Scholar
  22. 22.
    G. Srivastava, K. Singh, M. Talat, O.N. Srivastava, Kayastha AM functionalized graphene sheets as immobilization matrix for fenugreek β-amylase: enzyme kinetics and stability studies. PLoS ONE 9(11), e113408 (2014). doi: 10.1371/journal.pone.0113408 CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Nanoscience and Nanotechnology Unit, Physics and Bioscience DivisionBanaras Hindu UniversityVaranasiIndia

Personalised recommendations